Gainers
Avenue Therapeutics (NASDAQ:ATXI) stock increased by 17.2% to $0.7 during Thursday's after-market session. The company's market cap stands at $14.5 million.
Gainers
Quidel (NASDAQ:QDEL) shares increased by 7.4% to $106.2 during Friday's after-market session. The market value of their outstanding shares is at $4.4 billion.
Gainers
Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.
Gainers
Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
Gainers
Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.
Femasys Inc. (NASDAQ:FEMY), a biomedical company developing a suite of product candidates to transform women's healthcare with minimally invasive, non-surgical, in-office technologies, today announced the appointment
Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.52) per share. This is a 133.55 percent decrease over earnings of $1.55 per share from the same period last year.